MedPath

A clinical intervention to evaluate the efficacy of Panchakola gruel Vaishwanara Powder Enema followed by Nirgundi ghana tablet and Panchakola gruel Vaishwanara Powder Enema followed by Simhanada Guggulu in Rheumatoid Arthritis

Phase 2
Conditions
Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Registration Number
CTRI/2024/07/070997
Lead Sponsor
IKITA RATHEE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with lakshanas of Amavata

2.Patients of either gender within age group of 18 years to 60 years

3.Patients with Amavata who are fit for Basti Karma

Exclusion Criteria

1.Chronicity of more than 5 years

2.Patients of Amavata having any deformity

3.Patients diagnosed with other systemic disorders interfering with the course of treatment

4.Pregnant & lactating women diagnosed with Amavata

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To see the effect of both the drugs in reducing the symptoms of Amavata and any changes in investigations if presentTimepoint: 1.Before treatment baselinen <br/ ><br>2.8th day - after panchakola yavagu <br/ ><br>3.16th day - After Basti <br/ ><br>4.After 30 days - After oral medicines
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath